Sunshine Biopharma (SBFM) Other Non-Current Assets (2017 - 2026)

Sunshine Biopharma (SBFM) reported Other Non-Current Assets of $71740.0 for Q1 2026, down 92.75% quarter-over-quarter from $989572.0 in Q2 2019.

Sunshine Biopharma (SBFM) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Sunshine Biopharma has reported Other Non-Current Assets for 4 years, with the latest figure at $71740.0 in Q1 2026.

For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $71740.0; the trailing twelve-month figure through Mar 2026 stood at $71740.0 (changed N/A YoY), and the FY2018 full-year result was $989572.0, up 1132.5% from the prior year.
Other Non-Current Assets for Q1 2026 stood at $71740.0, down from $989572.0 in the prior quarter.
The five-year high for Other Non-Current Assets was $71740.0 in Q1 2026, with the low at $71740.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	1.79 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	351.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	233.20 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	3.45 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	73.60 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	295.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	59.36 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	47.63 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-
10	Sunshine Biopharma	10.94 Mn	4.03 Mn	2.18 Mn	71,740.00

Download Data